利爾化學(002258.SZ)業績快報:2020年度淨利升97.72%至6.15億元
格隆匯1月20日丨利爾化學(002258.SZ)披露2020年度業績快報,實現營業總收入49.69億元,同比增長19.33%;營業利潤7.81億元,同比增長80.72%;利潤總額7.81億元,同比增長77.49%;歸屬於上市公司股東的淨利潤6.15億元,同比增長97.72%;基本每股收益1.1732元。
2020年,面對國內外新冠疫情形勢持續嚴峻的局面,公司積極應對,對外全力開拓國內外市場,對內加強安全環保管控、挖潛降本,千方百計保障原材料供應以確保生產運營。公司營業總收入較去年同期增加19.33%,受公司部分產品的銷量及銷售價格上漲等因素,公司業績實現同比上升,公司營業利潤、利潤總額、歸屬於上市公司股東的淨利潤以及基本每股收益分別較去年同期增加80.72%、77.49%、97.72%、97.72%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.